Medicine and Dentistry
Therapeutic Procedure
100%
Patient
75%
Secondary Care
63%
Randomized Controlled Trial
63%
Crohn's Disease
63%
Faecal Calprotectin
63%
Symptom
63%
Medical Care
45%
Social Adaptation
27%
Patient Health Questionnaire 15
18%
Spontaneous Remission
17%
Gene
11%
Patient Health Questionnaire 9
9%
Mood
9%
Syndrome
9%
Cost-Effectiveness Analysis
9%
Arm
9%
Medically Unexplained Physical Symptoms
9%
Retrospective Study
5%
Sensitivity and Specificity
5%
Analysis
5%
Patient with Crohn's Disease
5%
Marker
5%
Biochemistry, Genetics and Molecular Biology
Gene
74%
Sequencing
63%
BTNL2
63%
Immune-Related Gene
63%
Exon
15%
Genotyping
15%
Major Histocompatibility Complex
15%
S100A9
5%
Nursing and Health Professions
Secondary Health Care
63%
Standard
36%
Behavioral Intervention
27%
Randomization
9%
Cost Effectiveness Analysis
9%
Medically Unexplained Symptom
9%